These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158 [TBL] [Abstract][Full Text] [Related]
8. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840 [TBL] [Abstract][Full Text] [Related]
9. Comparison of hetastarch with albumin for postoperative volume expansion in children after cardiopulmonary bypass. Brutocao D; Bratton SL; Thomas JR; Schrader PF; Coles PG; Lynn AM J Cardiothorac Vasc Anesth; 1996 Apr; 10(3):348-51. PubMed ID: 8725415 [TBL] [Abstract][Full Text] [Related]
10. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. Navickis RJ; Haynes GR; Wilkes MM J Thorac Cardiovasc Surg; 2012 Jul; 144(1):223-30. PubMed ID: 22578894 [TBL] [Abstract][Full Text] [Related]
11. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090 [TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial. London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660 [TBL] [Abstract][Full Text] [Related]
13. Postoperative blood loss and transfusion associated with use of Hextend in cardiac surgery patients at a blood conservation center. Moskowitz DM; Shander A; Javidroozi M; Klein JJ; Perelman SI; Nemeth J; Ergin MA Transfusion; 2008 Apr; 48(4):768-75. PubMed ID: 18248568 [TBL] [Abstract][Full Text] [Related]
14. Platelet inhibitors and hydroxyethyl starch: safe and cost-effective interventions in coronary artery surgery. Hicks GL; Jensen LA; Norsen LH; Quinn JR; Stewart SS; DeWeese JA Ann Thorac Surg; 1985 May; 39(5):422-5. PubMed ID: 2581521 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis. Van der Linden P; Dumoulin M; Van Lerberghe C; Torres CS; Willems A; Faraoni D Crit Care; 2015 Mar; 19(1):87. PubMed ID: 25886765 [TBL] [Abstract][Full Text] [Related]
16. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909 [TBL] [Abstract][Full Text] [Related]
17. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Diehl JT; Lester JL; Cosgrove DM Ann Thorac Surg; 1982 Dec; 34(6):674-9. PubMed ID: 6184023 [TBL] [Abstract][Full Text] [Related]
18. Why the Food and Drug Administration changed the warning label for hetastarch. Haynes GR; Havidich JE; Payne KJ Anesthesiology; 2004 Aug; 101(2):560-1. PubMed ID: 15277957 [No Abstract] [Full Text] [Related]
19. Effects of Perioperative Fluid Replacement Therapy in Lung Transplant Patients. Björkbom E; Hämmäinen P; Schramko A Exp Clin Transplant; 2017 Feb; 15(1):78-81. PubMed ID: 27855591 [TBL] [Abstract][Full Text] [Related]
20. Priming and replenishment in cardiopulmonary bypass with hydroxyethyl starch 130/0.4 decreases fluid overbalance without renal dysfunction or bleeding in adult valve surgery. Isoda S; Izubuchi R; Yamazaki I; Nakayama Y; Yano Y; Masuda M Gen Thorac Cardiovasc Surg; 2019 Apr; 67(4):374-376. PubMed ID: 30805825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]